631 filings
Page 12 of 32
8-K
xm5ow1b4iwiqeu5cd 9a
24 Dec 14
Other Events
12:00am
UPLOAD
mw45m
22 Dec 14
Letter from SEC
12:00am
8-K
g7r4x0p797s510s0g
8 Dec 14
BioDelivery Sciences Announces Completion of Randomization
12:00am
8-K
btp u3ocmwulr
6 Nov 14
BioDelivery Sciences Provides Business Review and Update
12:00am
8-K
3phyd0n9mf0ifcp
3 Nov 14
BUNAVAIL Is the First and Only Buccal Film Formulation of Buprenorphine and Naloxone for the Maintenance Treatment of Opioid Dependence
12:00am
8-K
31wjpwm4rjjj ndld4i
31 Oct 14
BioDelivery Sciences to Develop a Long-Acting Injectable Depot Formulation
12:00am
8-K
5so6x
12 Aug 14
BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA
12:00am
8-K
d56mmk qi
8 Aug 14
BioDelivery Sciences Provides Business Review and Update
12:00am
8-K
s3a11ch51mrj2mz
6 Aug 14
BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial
12:00am
8-K
zpozxt q7kc
22 Jul 14
BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors
12:00am
8-K
zkj7otd
18 Jul 14
Departure of Directors or Certain Officers
12:00am
8-K
1x90jom5rtr3t wj
7 Jul 14
Other Events
12:00am
CT ORDER
m2t 2ouiud
7 Jul 14
Confidential treatment order
12:00am
8-K
ql24x3d
26 Jun 14
BioDelivery Sciences Announces Completion of Patient Enrollment in its Initial Phase 3 Trial of Clonidine Topical Gel for Painful Diabetic Neuropathy
12:00am
8-K
jb0w6zi
9 Jun 14
Other Events
12:00am
8-K
znok n77svld
9 May 14
BioDelivery Sciences Provides Business Review and Update
12:00am